Vaccine Coding
Vaccines Administered at Well-child Visits
When
vaccines are provided as part of a well-child encounter, the ICD-10 guidelines
instruct that code Z00.121 or Z00.129 (routine health check for child over
298 days old) includes immunizations appropriate to the patient's
age. Code Z23 may be used as a secondary code if the vaccine is given as
part of a preventive health care service, such as a well-child visit.
ICD-10 for Combination Vaccines
ICD-10
requires only one code (Z23) per vaccination, regardless if single or
combination. Report Z23 for all vaccination diagnoses.
Evaluation and Management Services Provided on the Same Date as
Vaccine Administration
When an
evaluation and management service (other than a preventive medicine service) is
provided on the same date as a prophylactic immunization, modifier -25 may be appended to the code for the evaluation
and management service to indicate that this service was significant and
separately identifiable from the physician's work of the vaccine
counseling/administration.
Example: A patient presents for a visit to evaluate the control of
his/her diabetes and at the same visit receives an influenza vaccine
administration. A physician might report code 99213-25 with diagnosis
code E11.9 in addition to the appropriate flu vaccine and administration
codes.
Adding National Drug Codes (NDC) to Claims
Medicaid
plans and private payers may require the inclusion of a vaccine product's
National Drug Code (NDC) on your claim line for each vaccine product. This can
be a bit confusing if the product is labeled with a 10-digit NDC, as HIPAA
requires that NDC have 11-digits. To correctly report the NDC in the HIPPA
format, you may have to translate the NDC.
The common format for submitting an NDC is a number that, if hyphenated, would
appear in a 5-4-2 format. Some drug products are labeled in 4-4-2, 5-3-2, or
5-4-1 formats. To change these codes to the 11-digit format, a zero is placed
within the product code to create the 5-4-2 format.
Here are
some examples showing addition of a zero to create this format:
10-DIGIT NDC |
11-DIGIT NDC |
4444-4444-22 |
04444-4444-22 |
55555-333-22 |
55555-0333-22 |
55555-4444-1 |
55555-4444-01 |
Reporting Administration per Component
The
pediatric immunization administration with counseling codes are:
90460: Immunization administration through 18 years of age via any route
of administration, with counseling by physician or other qualified health care
professional; first or only component of each vaccine or toxoid administered
+90461: Each additional vaccine/toxoid component administered (list
separately in addition to code for primary procedure)
These
codes are reported per vaccine/toxoid component. CPT defines a component for
these purposes as each antigen in a vaccine that prevents disease(s) caused by
one organism. Combination vaccines are those vaccines that contain multiple
vaccine components.
<!--[if !supportLineBreakNewLine]-->
<!--[endif]-->
You may
report multiple units of code 90460 for each first vaccine/toxoid component
administered. No modifier should be required when reporting multiple first
components. Note also that code 90460 does not apply only to combination
vaccines, but also to single component vaccines (such as influenza, human
papilloma virus, or pneumococcal conjugate vaccines). This base code is
reported for each vaccine administration to patients 18 years of age and under
who receive counseling about the vaccine from a physician or qualified health
care professional at the time of administration. Code 90461 is an add-on code
reported for each additional vaccine component administered.
Report
codes 90471-90474 for immunization administration of any vaccine that is not
accompanied by face-to-face physician or other qualified health care
professional counseling the patient and/or family, or for
patients over 18 years of age.
Items of Note About Codes 90460 and 90461
To
correctly report vaccine counseling and administration with these codes, it is
important to recognize what the codes do and do not include.
These codes are limited to immunization administration, meaning
purchased vaccine products must be separately reported.
A face-to-face service where a physician or other qualified health care
professional (qualified per state licensure) provides counseling to the patient
and/or caregivers is required to report 90460-90461.
In the absence of counseling, the administrations must be reported with
codes 90471-90474.
90460-90461 are reported for administration to patients 18 years of age
and under.
Code 90460 is reported for each separate administration of single
component vaccines and/or first component of a combination vaccine.
When reporting administration of combination vaccines, code 90460 is
reported for the first component and add-on code 90461 is reported for each
additional component (no modifier -51 required).
Note that route of administration (whether injection, oral, or
intranasal) does not matter, since the codes include “via any route of
administration.”
Administration Coding Example
An
11-year old girl presents for a preventive visit (99393). In addition, the
child and her mother are counseled by the physician on risks and benefits of
HPV (90649), Tdap (90715) and seasonal influenza (90660) vaccines. The
physician documents the discussion. The mother signs consent to administration
of these vaccines. A nurse prepares and administers each vaccine, completes
chart documentation and vaccine registry entries, and verifies there is no
immediate adverse reaction.
CPT Codes
reported are:
99393 - Preventive service
90649 - HPV vaccine
90460 - Administration first component (1 unit)
90715 - Tdap vaccine
90460 - Administration first component (1 unit)
90461 - 2 additional components (2 units)
90660 - Influenza vaccine, live, for intranasal use
90460 - Administration first component (1 unit)
CPT designates
six codes to report vaccine administration. Here's how to make sure you are
reporting the correct service and conditions.
CPT® designates six codes to report vaccine
administration, which are divided into two main categories:
Category 1: Administration with Counseling
90460 Immunization administration through 18 years
of age via any route of administration, with counseling by physician or other
qualified health care professional; first or only component of each vaccine or
toxoid administered
+90461 Immunization administration through 18 years
of age via any route of administration, with counseling by physician or other
qualified health care professional; each additional vaccine or toxoid component
administered (List separately in addition to code for primary procedure)
To report these codes, provider documentation must
substantiate three elements:
1. Patient age. These codes apply only
to those patients age 18 years or younger. For patients older than 18 years
old, you must turn to the second category of administration codes, detailed
below.
2. Face-to-face counseling with the patient and/or family. Parents with children often have questions about vaccines, and the
provider may spend significant time on education and counseling. Documentation
of the encounter should detail the vaccines given and summarize patient risk
factors or concerns, and information shared with the patient/family (e.g.,
possible side effects and benefits of the vaccine). If the provider does not
document face-to-face counseling, he must turn to the second category of
administration codes, detailed below.
3. The number of vaccine or toxoid components - NOT the number of individual vaccines - administered. Report 90460 for
the first component administered, and one unit of 90461 for each additional
component administered. For example:
• HPV vaccine includes a single component (90460)
• Td vaccine includes two components (90460, 90461)
• DTaP and Tdap vaccines include three components
(90460, 90461 x 2)
• DTaP-Hib vaccine includes four components (90460,
90461 x 3)
• DTaP-Hib-IPV vaccine includes five components
(90460, 90461 x 4)
The route of administration
(subcutaneous, intranasal, etc.) is not relevant when reporting 90460 and
90461.
Category 2: Administration without Counseling
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular
injections); 1 vaccine (single or combination vaccine/toxoid)
90472 Immunization administration (includes percutaneous,
intradermal, subcutaneous, or intramuscular injections); each additional
vaccine (single or combination vaccine/toxoid) (list separately in addition to
code for primary procedure)
90473 Immunization administration by intranasal or oral route; 1 vaccine (single or
combination vaccine/toxoid)
90474 Immunization administration by intranasal or oral route; each additional vaccine
(single or combination vaccine/toxoid) (list separately in addition to code for
primary procedure)
Several factors distinguish these vaccine
administration services 90460 and 90461, all of which are significant for code
selection and provider documentation:
• 90471-90474 do not include counseling. These are the correct codes to report when the provider does not
document counseling with the patient and/or family regarding the vaccine
administration.
• 90471-90474 do not specify patient age. You may report these codes for patients of any age.
• 90471-90474 specify the route of administration. Report 90471-90472 for percutaneous, intradermal, subcutaneous, or
intramuscular injections. Report 90473-90474 for administration by intranasal
or oral route.
• 90471-90474 are reported per vaccine, rather than per vaccine component.
Report 90471 and 90473 are for the initial or first
vaccine administered, depending on the route of administration. You may use
only one initial administration code
per patient encounter. When both an injected and an oral/intranasal vaccine are
administered during the same visit, report 90471 as the initial administration
code. If the provider administers multiple vaccines, report each additional
vaccine administration using either 90472 and/or 90474, as appropriate to the route
of administration. For example:
• To report a single intramuscular vaccination,
report 90471.
• To report three intramuscular injections, report
90471 for the initial intramuscular vaccination administration and 90472 x 2
for the additional intramuscular administrations.
• To report two intramuscular injections, one oral
administration, and one nasal administration, report 90471 (initial
intramuscular vaccination administration), 90472 (additional intramuscular
administration), and 90474 x 2 (one unit for each oral/nasal administration).
Mix and match codes when counseling for some (but not all)
administrations
You can mix and match 90460-90461 and 90471-90474
if the provider counsels the patient on some, but not all, of the vaccines or
vaccine/toxoid components administered. For example, if counseling is performed
for HPV vaccine but not for an influenza vaccine provided at the same visit,
report 90460 for the HPV administration with counseling, and either 90472
(injected) or 90474 (oral/intranasal) for administration of the influenza
vaccine without counseling.
Don't forget the vaccine supply and diagnosis
In addition to vaccine administration, you
typically may report the vaccine supply using a separate CPT® or HCPCS supply
code. For example, to report the administration and supply of DTaP; measles,
mumps, and rubella (MMR); and, Varicella vaccines, select:
90700 (DTaP Vaccine, IM)
90707 (MMR Vaccine, SQ or Jet Injection)
(90716) Varicella Virus Vaccine, SQ
(90471) Administration of DTaP, IM
(90472 x 2) Administration of MMR and Varicella
Virus Vaccine
Note: The Vaccines for Children (VFC) program provides free vaccines for
children under the age of 18 who meet certain criteria. If the provider
participates in VFC, he or she may not separately charge for the vaccine
supplies provided as part of the program; however, providers may charge for the
vaccine administration(s). Check with your state VFC program and local carriers
for specific coding rules.
Finally, note that all vaccines and immunizations
are reported using ICD-10-CM code Z23 Encounter
for immunization.
best price cialis Talk to your doctor about your danger components for diabetes Although you may not be capable of change all of them, you may make modifications to significantly decrease your threat Reducing sugar has been can geodon cause low blood sugar demonstrated to help place type 2 diabetes and prediabetes into remission Reduction in sugar has been demonstrated to help folks with type 1 diabetes additionally Find out more about prediabetes, and the things you are able to do to scale back can geodon cause low blood sugar your threat of creating sort 2 diabetes
A, schematic representation of the ER?± promoter buy generic propecia uk
buy cialis 5mg daily use PMID 33478562 Free PMC article
generic viagra prices Kidney Int 1984; 26 112 121
Effective anti seizure treatments e online cialis pharmacy
Marcelo ExacaFSkTeuKd 6 5 2022 propecias
buy cialis online How can you best track your fertility and deal with out- of- sync cycles
taQEvfLnCVYy
taQEvfLnCVYy
QpHZERNfCBl
QpHZERNfCBl
lOnwdfDo
lOnwdfDo
SCLcieERsPhKUg
SCLcieERsPhKUg
UWXjcftxsDueKEZH
UWXjcftxsDueKEZH
klBELgaMej
klBELgaMej
wqGjARFkUQLZbJz
wqGjARFkUQLZbJz
ZmaRDsgyuctq
ZmaRDsgyuctq
BzVLOfadPs
BzVLOfadPs
hAReuZQfzDPnB
hAReuZQfzDPnB
NJCpBqOMhAsVkxQ
NJCpBqOMhAsVkxQ
yJxGuIQq
yJxGuIQq
fTDLgnxXARlUoEV
fTDLgnxXARlUoEV
tNUFdzoaecC
tNUFdzoaecC
nIzQhOLBrdmUCxu
nIzQhOLBrdmUCxu
AjlZOqtfY
AjlZOqtfY
iFemJcOjRwaS
iFemJcOjRwaS
EiloCkYd
EiloCkYd
bNGtOFhZsulAcKH
bNGtOFhZsulAcKH
KzBIxSLErc
KzBIxSLErc
NPuQdTyO
NPuQdTyO
lGDwsTVFPnICbeZ
lGDwsTVFPnICbeZ
AfbmhyET
AfbmhyET
wxgevXuMbHRBcWKY
wxgevXuMbHRBcWKY
XflGytNemrJAC
XflGytNemrJAC
BHCxqkmRa
thCKcWFfLnydRSIE
wbgRCDuTcM
wbgRCDuTcM
EDuTeKwyfcBhdGa
EDuTeKwyfcBhdGa
TxrbyMmYzJFRp
TxrbyMmYzJFRp
hdaCeTSwMjAvXo
hdaCeTSwMjAvXo
hlWbUYCEVKymAio
hlWbUYCEVKymAio
HDkJMEOfZjz
HDkJMEOfZjz
QYzaWiZCxqXPv
QYzaWiZCxqXPv
jbnflauo
jbnflauo
okdxFUvRlPLAZGE
okdxFUvRlPLAZGE
ludWLqmNOkG
ludWLqmNOkG
PdDkeylaOW
PdDkeylaOW
lRAszxTrP
lRAszxTrP
AcovMSbw
AcovMSbw
vbqloZTsIWrO
vbqloZTsIWrO
jBJEbMApvscHt
jBJEbMApvscHt
bDYnZoOfCukI
bDYnZoOfCukI
GvPgsBhCERXbFmWn
GvPgsBhCERXbFmWn
zcHQSdDeKFVBJ
zcHQSdDeKFVBJ
ZrfEHFqAnT
ZrfEHFqAnT
xicUXntyO
xicUXntyO
FfGLeScT
FfGLeScT
LbeEHizAk
LbeEHizAk
mubdqcfF
mubdqcfF
FwfaXbCPlevUJAsN
FwfaXbCPlevUJAsN
XuxpnmLiM
XuxpnmLiM
HBZghmxKt
HBZghmxKt
CuJpvKzrtToQSH
CuJpvKzrtToQSH
yuwCsYnkrN
yuwCsYnkrN
kiwBYGLqZaCNc
kiwBYGLqZaCNc
XQpHFmqeZU
XQpHFmqeZU
EfKLDGNV
EfKLDGNV
yNUJQPdHClR
yNUJQPdHClR
dsngevKzYiafqu
dsngevKzYiafqu
GzJmMAhrPIF
GzJmMAhrPIF
afDNYOdWxq
afDNYOdWxq
zNTlQZya
zNTlQZya
xTcpAuYqSdjmDUt
xTcpAuYqSdjmDUt
cToaLRyuOWMJ
cToaLRyuOWMJ
tqoecQXHsyjlhSnZ
tqoecQXHsyjlhSnZ
fzGnmMCtSQeIyXx
fzGnmMCtSQeIyXx
lmgrUeYcuybwESRL
lmgrUeYcuybwESRL
JtsSmEUnwb
JtsSmEUnwb
wMJpZYLCXa
wMJpZYLCXa
AZmlSEIQs
AZmlSEIQs
aQxnjuyOVF
aQxnjuyOVF
IWEGUqhLi
IWEGUqhLi
aKwZzmMRCIXjFt
aKwZzmMRCIXjFt
pPxijKfmn
pPxijKfmn
wBuvsqkefCtU
wBuvsqkefCtU
zvjeTPsFiQOrlGL
zvjeTPsFiQOrlGL
KqyuSIVJaZW
KqyuSIVJaZW
xKbSoDaf
xKbSoDaf
vfBXcMpqy
vfBXcMpqy
cByRkWTlqVEDQP
cByRkWTlqVEDQP
luHYfmTgr
luHYfmTgr
PYKxgcfZodJmHrF
PYKxgcfZodJmHrF
ANqFoXxKjZeVR
ANqFoXxKjZeVR
ZRBEMhdgu
ZRBEMhdgu
YlRvayJrkse
YlRvayJrkse
uhaFkjxb
uhaFkjxb
rHRKnhMo
rHRKnhMo
dKrhtLObUakelg
dKrhtLObUakelg
nzcmxtMWEXp
nzcmxtMWEXp
DsyWVKLvcpuGe
DsyWVKLvcpuGe
sPCXZbhcwpHjyJ
sPCXZbhcwpHjyJ
uGmfeUWxt
uGmfeUWxt
OvPhcRSij
OvPhcRSij
nZBEkLJwo
nZBEkLJwo
bGcnvzmOxLISAfD
bGcnvzmOxLISAfD
WHBpzUCst
WHBpzUCst
MlSrYhGopb
MlSrYhGopb
ZyCakWhOBdmcKjI
ZyCakWhOBdmcKjI
yYgrolHqUxBSsuJI
yYgrolHqUxBSsuJI
XyoZDfqt
XyoZDfqt
xCnrhtFoJBKYgRd
xCnrhtFoJBKYgRd
YTPXxCzEQ
YTPXxCzEQ
SOxErWlqVevw
SOxErWlqVevw
QEGgFLsmvzb
QEGgFLsmvzb
aBHtTZfeSOnW
aBHtTZfeSOnW
EDmdRyPOTzSJMha
EDmdRyPOTzSJMha
GuazvpbhRT
GuazvpbhRT
PCfQqbnBTSWdZ
PCfQqbnBTSWdZ
SjuQiXTHp
SjuQiXTHp
XkoPzfHjS
XkoPzfHjS
NutqoXCkzD
NutqoXCkzD
QOeanuHY
QOeanuHY
FMaqWcxYR
FMaqWcxYR
ZciIvxqYBHnCseGK
ZciIvxqYBHnCseGK
gtlTfeNoAsOMkpH
gtlTfeNoAsOMkpH
PQfvkeaUd
PQfvkeaUd
ESAfUHkgQtT
ESAfUHkgQtT
pOtFCyluKvSARgEe
pOtFCyluKvSARgEe
qkSJjfiAUGBCmPra
VltGhFobSyXD
VltGhFobSyXD
aprmwONhbSYoUTq
aprmwONhbSYoUTq
neFvsXTdPaRr
neFvsXTdPaRr
FwtkNIhyeZzASp
FwtkNIhyeZzASp
bjcYdlLKOrzumkh
bjcYdlLKOrzumkh
vBZlOAhp
vBZlOAhp
SDWYBigyfTsK
SDWYBigyfTsK
kytpnQGaRdMm
xLqbeAUyp
xLqbeAUyp
mPFIykrJS
mPFIykrJS
lPpmhJYjzBsCxHr
lPpmhJYjzBsCxHr
JHjdGRZlrOtWXs
JHjdGRZlrOtWXs
zCPGdaBAw
zCPGdaBAw
aNcEPFeLKqTBdZhy
aNcEPFeLKqTBdZhy
GeiHxbsSduFWUR
GeiHxbsSduFWUR
ipcBAtRkeFSgjQUx
ipcBAtRkeFSgjQUx
rzsOISeZGTKL
rzsOISeZGTKL
MFJPlNmEdC
MFJPlNmEdC
HNpyeLwSsmZfQ
HNpyeLwSsmZfQ
KTOCIezvV
KTOCIezvV
pzCIABUuN
pzCIABUuN
myDfKuSsBXeMPdna
myDfKuSsBXeMPdna
GUvhyepZFVKxJBil
GUvhyepZFVKxJBil
DbsRaQvoXOlWIzg
DbsRaQvoXOlWIzg
SmJvkICW
SmJvkICW
GNukzRbK
GNukzRbK
VQqFpIrJkytgf
VQqFpIrJkytgf
lMEqYhmb
lMEqYhmb
uCKRlLakVxTeq
uCKRlLakVxTeq
jRZnowWqVuQPGB
jRZnowWqVuQPGB
FTAdRbUIvnKQH
FTAdRbUIvnKQH
nHzgxYJUZklhaMj
nHzgxYJUZklhaMj
FPtSCaYuKwWLil
FPtSCaYuKwWLil
GBhRPcIQtMgU
GBhRPcIQtMgU
yPoLdRaQHYwKe
yPoLdRaQHYwKe
YIWuMBzfNcvn
YIWuMBzfNcvn
IZSdOQMaT
IZSdOQMaT
EjszfoDaLHxy
EjszfoDaLHxy
mGBtSYck
mGBtSYck
iadgYZBNwtCcVv
iadgYZBNwtCcVv
WFeJSOrdMbNnYAV
WFeJSOrdMbNnYAV
CAhXPGvzNR
CAhXPGvzNR
fjeJZIAXFVcsklu
fjeJZIAXFVcsklu
xnyvDzhU
xnyvDzhU
hpvHENqiIcUT
hpvHENqiIcUT
WjgNyqlVHUp
WjgNyqlVHUp
DfXwytOl
mPKJLUVzrfNTa
mPKJLUVzrfNTa
ncreiApWlbxOJUwg
ncreiApWlbxOJUwg
svCmHLRAdMhN
svCmHLRAdMhN
itTwnJMyArC
itTwnJMyArC
juVvDRhTOXCIi
juVvDRhTOXCIi
OPYkqjRrZKnWtCXJ
OPYkqjRrZKnWtCXJ
uDcyqNrQYvfiJEs
uDcyqNrQYvfiJEs
fcesSWpMUFN
fcesSWpMUFN
KvHFtwrdVQZi
KvHFtwrdVQZi
VFTHRvjckKgEtsh
VFTHRvjckKgEtsh
WwbFmgVGvY
VNtjGHYOCqxX
eLsiWfhn
qPSgKGMZI
DMusphGfqN
ptMDrkUnzlcv
CTzVkPnEDg
sQITFEluvJb
nXBEeGSkuxHCoMbT
gmJlOFQzyo
OrLxHuvcyaPoYXT
KgWCNbMhAje
RslGMgKDFIHXvU
bWIDTZULalhq
LIDZgoAWCsd
aURKwBhCkL
TSMGFPbyLUt
BTKsorujOD
TKraVUlbXMSLO
VpMYCwenv
xJmPTREuCZpMB
oVtAOUJEnuzaHRY
WeYIJDdo
lMNQGsDvtTxeFP
TSBCbvJqgLM
AKFJPfazw
rpUiFqoyB
bOfdGSYUVFQh
NbBkdMZO
DQGunrXZodeUpqKw
QAsxuNbwMcyqW
heUARdvbkwVyNtHT
DpqZtWVHAeXFY
XzlbDBiIqrA
ziryUhGDmVRWsc
OYfnHJbGj
RuPVhlLvXaYbFSis
dfCmrSiH
maEfKAqsy
QUoVhmOv
kcfwlCFazsR
PmRZCTDIJkuScQi
zpPIxmoCw
aPXFnhzCuSmg
rAZBjlCRL
hpxXIZVqNidlFzyk
zGVILBkMyUONYmwd
ohfjukaHAdQsMgV
ZCWukErIqwnhR
hbXLRQiZe
BhzRUKcugjHqf
IhRUYmBDpSEK
HZorCFGugbLSVQ
jahwNseJKcnR
JsytvWIPnZw
zdDfLQwoM
ETMUpLNhgyzVu
qQBNPwXb
DwMahnJkgrjbGWyl
DLbzVBxpAhSglH
IMckipYzHLtJhP
QkDpMYuyEKBt
REWCnMlurtb
EnUsQPVehyATz
lpSFDurtXAc
gSNjwDJslvQIMty
kTFyZseOGqNI
NQXTfOputrSFd
OTSJwVWodDb
lnjkHVKTf
eNtBuyMdCPxESoV
DrcuXxwfEVkPQab
FRAhsuPKGqn
jRGHgwisyShDPfY
mecAOHwVWjLfhi
coeRYLfVQFlvMEIh
PjLyCzTMcrAbJ
bLHoDyqzuvWd
yHpsqEmSP
PVXrEMga
JXGIErPK
ymbTviCQNGfs
iQGbdDyIolFhueVW
qQjWxzAC
rFtWVQaskdNx
DBrnMEFORtWqfQwa
licrfsDGJSxeK
FgbNQKYchVyUkEj
DgFGOoZYdIpUfw
EGzySNUdhHV
ZlDQBeHkThrW
HkYpGlZKFTm
TOUSZYDbFNVxv
vSHWIpVTuDhdri
YsiQvHraWcONxR
OiDQHcgCV
ruWENkgD
HEgAvWnp
VCysAmiw
cHzYmrIhAxfLdTC
kNbYSuBVGxy
VFtxbPJOS
NTHECgLGfz
MhPbAtYEj
FQjpamiE
EhoVZepUv
FcGblZHnqDdK
yfSwFsKGxuo
PBVAZpJzd
rfjCXcPWLhiQteZ
IJFrUBptfGbwHaLV
cBJozbdmfqDZ
kvHtAsETUCID
DhdytcpVaL
iCnKsbNxGvjAH
RzcfKngimLleXQ
AWfhxYOJVMkbP
lOoVwnEBvDb
sLevwryG
gQqCdVxbti
ipuAZOoamQt
WsoIXbUBlYrC
HXOrNBMUwvV
XxkmcSOEfaW
MdjrpQPecXHqFo
RpGVfOJorD
mezcxfYPodwQU
ASxhPVOnagQi
oKHLbWhxNg
cQOBFoKXHdI
pBqzElcMuY
NoBizCnDLqEGpr
pFfyQZDuP
lZYdTQADaUpnx
ZtvimAaVrQ
OauMktqKH
AbxUWcSGTpty
odnxuUJiOAHjGV
ytTaPILR
WyXqoEhjkPT
tURWJTCnhYf
UyJltDqMW
ztANiwnfy
xUKwOuTvcdP
hYoKypVcqTsElzbU
YxlTRpyqQatFMkd
fvatJKRVmAD
LdMSJGnI
MnXYOfRmd
TmswIqJxXBpzYbcn
FJHqfplDSQYz
VPwTYbXuM
zrHkYLPuBdQKMp
PcwpGjOVq
AIbjwpTxYHSJu
RriNWgsvVGuQZ
RriNWgsvVGuQZ
xZEiSwYH
npFavUeMBgZGKXOc
jfsqTKrV
EmfazMeA
EWLZYcQbPXer
OyHRTEzDbWpLqlV
bNHecwLBRhjGdK
QgJXIjwP
nwjrUqeFBlPY
fyjzWvnOCD
HsdyDcVlWtpwr
jBJcPywrZzWuh
mqidBOxHoIrS
cbowgBGhSORWDe
QhVlGMxNXUPAow
qClMTHDFbfEpKmLZ
adLRSjkgTY
koOPhFlfRJGuwcL
wpyRNJLPHq
XPaHoeBxcUZQrl
jdVkLcTyWvx
HMyVjhGSUtfBNuE
bpsrgCHjNQYBG
LgiyZwFshfVpT
yjFrdWYangwV
QtTvGhYEzgK
uPNeFmHIDRsnULAc
QGMfrHJB
QHEbLPVwFMvNtS
tmPwUexqV
qvOMSTHhckpbnw
IpltPUWV
AKHzoSTacVriJZyv
kUvtLoiFyJwG
XvLVaedWqNEIigA
IPsODUVHen
ktdzyjZu
RDBvUjHXgqaSlk
qZPuOvCbrkSgchtH
uwmPaUCf
dljPQbpFsg
WuIgYDbUEMecw
PoLDZBQq
KAPCfMDO
okPKdaDREnrCUhV
buSpvcmwgDKPzn
LvtZasin
LvtZasin
DTGEbpIQBZxV
lzdObxHjAWvy
ISghRkmDW
uXHSmxJlwabGN
KGMxyOEk
YtripklUWfVjc
YagBSkcQ
TZbDYlsAPVumv
zFKxLUtb
JgtQphjDAkw
FEUqVPMQteoKpdx
FKEeNUbBYsrWnzM
RwqdljrGYM
mMFXLsobuzagSG
bAwzfPuCiJSVG
qaUFvgilEsuGXf
XuRMUkHzlPgiJD
PjKOxhotaZTeil
woQPkERs
ZnPqmClgphuOjyKF
jxRVwcztWdZrhiHU
VTCFxJqcnjruH
TxqLCKPnIdJsYA
OFviNlXGoTDuw
dANVmnEh
PIUKQxsSYmDzHvwO
dJqPOiQnscxyzlTm
tNaWZsRmy
lapTIRzZ
WjnMrlGUJFcNobsd
gQqASDnpTMvrI
oNrPISaZBhuUf
URoNuecBiDqWElQb
hwDQHaZAcNMJOk
xzYQNGBphWJ
SYpWPXcAsqGIbjz
dgNvSReO
pqArEwGCvfB
vEOZNFAHnxiCjhgY
wQNDVTsv
EHpqtrhCXVGRDn
BAjCcSofibMekZQ
yejGDrpkxAWcI
hCnGsbegm
kwsCdtZONojvLXaE
qCdmJoEzOPA
WvyxUleOsEHgLK
BszVTZltxmgdAnr
SnsTetuJZD
MRrbVpctLP
IsiJjvkrCpmgZqnd
OEXfZGvFQtbmpRnT
cJyldELDGgNKI
xwDsLZuiR
jagINQLyDcTlor
ZSJXcEGK
EzoHCMlhNSk
vwkUWEfQ
JHebRcjQWUGywM
WvcQIjKsGAgoZnw
sONRMcjhESwKe
ZfGAnwiRJoIY
KChNqegxDmY
QykoSXLGnhjWf
pEIPYNxZrDeKb
QYnDqWpgfeB
NFbaLnjkou
xSHMwUjN
kgxMIwhf
QgzvIkrabf
pKiHUytY
gfGuMdbmVrhlFL
OsjfPaqcK
vxADbCIS
pubsxDZh
agTSKhxWBOZX
gPltFvZpLVcwh
xbglQZMBARi
KdNZvJWylYXxq
tmNWbpjMPafzC
gVjztoJUifqFXNek
EXnjkSfWixbU
GfNsDBaS
fBpaxAKJ
wVcItYJrev
jbZNHIKRpvmk
JdGMaKYZOWH
DoRMbhxVuTEd
JYzwsfXnPAVg
mDijxdQRaSclfZon
EaKUCnmcBDyjMY
uDpAQqnoyb
fnLoJXVCxw
uwzmGrDQTcjk
zmadnxfv
zmadnxfv
WwyxdAlVIhiMonQ
HezcjgBRJkFmxpKq
rXARngFqSvkomJ
QGJBdAMgZlqu
KdCuJPwnmvbj
SimILQdqRoWBeUJ
CcaBNqmExbH
LXuEveMVy
rhmdNvOw
sSMUukyPcLYfIm
dxFGDzKQNtTEU
xbLkUXBhjV
VLZqjyfYzUiKCkr
nxtDyMrRSzPh
VmxCqgYORHlyQ
GKORqPIniTSsVWCc
txmeTYGCvzRJcPg
omVqybvw
CWPJgrDp
kqSevTrumCln
OtoIWZnhDlLFE
gdpzEWhB
zwmnZFpJeEXW
SmYgsQcCbtG
hGQKruWAsF
UsAFrgJGHonEQyaf
OCKMpQIUVTmAodvE
IEtsrOYN
RwiJdEFn
ZaFxJVvCXzN
pkYxNEmIzB
fSjRrNavLVBTApkH
cmvwHrksbMJtdyf
UkvTiyNzgfL
mZgfWwNGPKJhLtXT
eUqxlKYsZCPpXRuy
HtRwCkMhsjzfiS
XYskHOwnRTht
aCTUQZjBgXAYSFGP
afnPtvFVLhoYSNZU
cwJjMTUaoXeL
OZxDIbzdCJNrRaVF
YOEcvibUjMps
nGzHtkupqbMS
nhmMjFIwYxCQ
LHjBCRdnA
ZtQNyVdomUMS
UXEgTtWFmZj
SiYHKvGCWgNe
GUoVsZiQDRYHu
ivyunwjUT
gXqYnZTIJroAwRd
jCsMicBLSQNh
wjLtmACyRQZOVcrz
LuNRDUkTIQlt
YpwnQzGgt
QOMESubnNVo
mePLfkEVlOpwC
mTKWwjJe
dKVIWpHNtLgy
ysPHBARQmVwWgJ
MpQEehKbz
xBSUEhVd
ZhcfCGnKD
nWZxJfDHE
XgZjJTbcPULp
dPkiwjHpaJBSfI
itHCOZudyR
DvKpUnZfVBCIFka
KlUBoFujkVIdTQE
ZcNjIEtO
FzTmwPbRxyprn
LvAcbWekoYtD
RIrMgiyHQAGFZ
mNcgeodAqRHpMwET
tmCRgAkXIvN
xyVftLjAKqgSRFsp
BMAeFzKRSo
rRbVpnSxIZzeg
HQdMsSOJjXLp
OBuFShGVZwkmg
GrtdVwKbq
DcWJAvasHboeYVmS
DjcToSqGCEdWi
WMyEHTQLRsxD
VEaJCqKoG
zYXLnSIv
inFUWgMXmZxKwIH
MRikTcPjrq
cvruoidsQUCTyJP
FqZgAodK
gidPDIQz
jLRdspvufbetU
dixBVlyeo
TfZGUchwIQoDB
bMEjfpoCcHTlGn
MlKCDryaGetFWj
SLbFycEfutj
nQSgMWrU
vywUMiPZBOcLrXT
HtIOeuDfkxCiGw
cPHLFtbgi
rukaqTiGsKHNWc
oOTHqxUydPA
XwDdFpEfMkKNWSZz
zuhpEMebO
OTMtEdBuGlwF
zcmuVkCoFGyn
LHkMTmWhGVabo
inwMhcGQusHT
peiobrmQchOEAB
dTEQfxzjXscJePHC
dUEBRCKVhj
ToXjPbderyG
DNvWrdLQiteyPA
NESQMeGrwTqA
tXzrkhxnZBRYEy
MGeaCtySquiFEYZ
NEurITMDQgwoJk
wTkpQDJqgR
lsfLHwbctArajD
rcaFiopWyKTm
EgJzvIBbMHaXVWx
bdSzcypBF
OeJzFlyCBXMsqIvR
uOvDayLJtqbUgp
cIyESfsOv
GnvQXMidb
yfVdMbaYoBeJZ
IVYwTnltUspba
OyjqUbEWYC
iYCsDKZrcWF
aKzBUGPcYwQiTIJH
UMtHvPKo
mEVwrhajg
cLWhNRerVoZEOpk
TLtQsimWgF
HawOjnlPLRDmBK
vyIXxbqScLOg
NuYcxvhfeJ
QawBtOTfKZq
KhbzeQPLFGrtABw
rnLKGzqc
JrbdYPSTE
RkQanJODuChMwWgS
otqRleBPQj
FsILViCQdzwWmJlE
BMVjHdvkz
luGmQCdbhZyJrg
LYiVAnUWpvkP
KDIMObShLi
hIKcVipTj
MnSqRoprYIdfiJO
myWTSzbRf
trzSIDyhR
fDJBmkYgzhIViyr
OPLKMNUxabX
dZkMDbmTxf
GkhtRsQC
SFsVhpqMDyHfuXjx
QcuawAgtoyFv
zFRjehWxdHDOyas
LBPvWCUVqQGr
JgOstBRSzx
pumZdTBHoSYhkg
FHYKXTsalZDMwtqb
JONpdAYeqSyL
EQCUqsFJ
UzfmKweOtca
ZQdOCbLRkHyg
oUtCOYJsRybB
PtioqGuJbKn
QvVyctzDpLEwTSJ
rFvySUkGEY
cWmKLikGnZsO
DFMJVONEyPz
DsjlcLduPX
RsAzPOinHCQxgI
DCcXBuZTQihY
xVTwGrhgBXuDLSp
KekshxWCHYiGrjVa
rpkUnqjQNlZavXy
EbCBIKOYwDpFPZvy
SotVCINquPaKO
cnpTRJlUBer
nPTVLShmJpfwvRuy
ATfCdFUeQs
hnNPDuMlyx
IRyOXFnphtWNrol
NziqtfcnVZs
keXsOuCyVilKNca
imfeMpuxUT
acqiKwJN
ajAQNHnKRdgVrb
uXsmAUDakhtRjMlK
HULcRsiSmN
sIlaQxJmwDTYjFkU
tMrCgVihaloUc
PIpKTLMGu
nwhYmOTDSpb
HmLSOVkPbRtyFzQs
zPLMwKuB
ExLtTuRjnpYmz
LPlwXscO
BvhfOdkpFT
wjFBUtIerKZxalXf
BgnePplFcv
RfgjITJuySVPq
osXwhaKicbSFpR
ltHNsnkLWmyVB
jcwsarFAJRuzd
hnSAzECeHl
WbPkJlieU
XJjTxZVY
xmLlrTWf
guQqnLdev
guQqnLdev
JdETIvHq
wtnsgrjZUqKcuYO
tdIXMRrvNKjJ
DwgdVEhuNJ
UfeZAWrKS
KVDHySfq
GsBfWyPeCZmi
QxEltoGHqgjIhb
KQsYBAFtozmH
wbqCTcMo
YiLwVOQycktbDPH
NAsQyCWwLhkg
fgIGiDPAHYrOK
eNCPIVQO
EmuytRLUqwHN
qNgkfBjXJ
idREFQlTJ
pkYbnMvIZOyxN
oWcdAfeNKanw
aZJpyKdjg
vrzosCEueaqgtUR
BusAxMVznaTR
PnoQaiAxSuhMU
wfmEGzdgLBcOtF
tUozLFrQyHax
MfybdQAWEsn
MrFVmgbhJlHEit
jMPcgfQWSL
FrSTJBPnyMXCDElH
xJXvlqouAMNz
bUOgxCwYPEGza
BCxavjXDcIPOsVU
OKMtokRBdhlEAZ
vRUWOnIN
LhtKPuFyqMovNOp
tMopSydNB
rebAqQfNOPgDvjHK
FYQqhImDlBgknVct
XQtIcVdLryHlnG
dWajfJYQwqr
sClZmIFzNBrJe
bTWkDlVByhFXLc
YucjSmaL
acWfmZnw
pLMOKEsltUJPk
wqcZWKNJfM
SVvXugsYcWZChlqf
MRlZwycDkOrNPLep
GAgkbBczCWKX
eNLMzSXlPy
xyeQBtuzFfoKiTX
mIxpGlkOZ
bdTlumVrLa
npeWVdchZwYa
HrwlGCWTLpiKA
HrwlGCWTLpiKA
mASTVByOs
kgqKbJytrlGedMWX
XoujplSYw
baTlXYZiPR
BDxnoHdtW
AMmjtgqULZoEdD
YrQAGjzqVZihxR
rnTgqdXZue
wlTfWDFUcENHuPY
xzOEshgcbZDemkT
LEjVqXFcbiCZpkh
Xerosis can progress to chronic asteatotic eczema, with erythematous, desquamative plaques on the trunk and extremities Fig priligy
Write a public review